The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen
Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myeloma (MM).
 
Benjamin Avi Derman
No Relationships to Disclose
 
Jeffrey A. Zonder
Consulting or Advisory Role - Alnylam; Amgen; Bristol-Myers Squibb; Caelum Biosciences; Celgene; Intellia Therapeutics; Janssen; Oncotherapeutics; Prothena; Takeda
Research Funding - BMS (Inst); Celgene (Inst)
 
Ankit J. Kansagra
Consulting or Advisory Role - Alnylam; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Pfizer; Pharmacyclics; Sanofi; Takeda
 
David L. Grinblatt
Honoraria - Alexion Pharmaceuticals
Consulting or Advisory Role - Celgene
Speakers' Bureau - Alexion Pharmaceuticals; celgene
 
Sunil Narula
No Relationships to Disclose
 
Shayan Rayani
No Relationships to Disclose
 
Andrew T Stefka
No Relationships to Disclose
 
Ken Jiang
No Relationships to Disclose
 
Sarah Major
No Relationships to Disclose
 
Brittany Wolfe
No Relationships to Disclose
 
Megan Whelan
No Relationships to Disclose
 
Bernadette Libao
No Relationships to Disclose
 
Amanda McIver
No Relationships to Disclose
 
Evangelia Andreatos
No Relationships to Disclose
 
Daniel Juergens
No Relationships to Disclose
 
Luis Alcantar
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Michael Russell Bishop
Employment - UnitedHealthcare
Honoraria - Celgene
Consulting or Advisory Role - AGIOS; Arcellx; Arcellx; Autolus; Bluebird Bio; BMS; crispr therapeutics; Iovance Biotherapeutics; Kite, a Gilead company; Novartis; Seagen
Speakers' Bureau - Agios; Bristol-Myers Squibb; Incyte; Kite, a Gilead company; Sanofi
Research Funding - Arcellx (Inst); crispr therapeutics (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BMS; Kite/Gilead; Novartis
 
Jagoda Jasielec
No Relationships to Disclose
 
Andrzej J. Jakubowiak
Consulting or Advisory Role - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics